Intuitive Q2 Revenue $2.89B, EPS $2.29; Procedures Up 16%
Intuitive Surgical announced strong financial results for the second quarter ended June 30, 2026, with revenue increasing 19% to $2.89 billion and GAAP diluted EPS rising to $2.29. The growth was driven by a 16% increase in worldwide procedures, including significant growth in both da Vinci and Ion procedures. The company also expanded its installed base of da Vinci and Ion systems and repurchased $0.38 billion in shares. Intuitive provided a positive outlook for 2026, expecting da Vinci procedure growth between 13.5% and 15.5%.
Key Highlights
- Q2 2026 revenue increased 19% to $2.89 billion.
- Q2 2026 GAAP diluted EPS was $2.29, up from $1.81 in Q2 2025.
- Worldwide procedures (da Vinci and Ion combined) grew approximately 16% year-over-year.
- Company placed 468 da Vinci surgical systems, including 246 da Vinci 5 systems.
- Da Vinci installed base grew 12% to 11,710 systems.
- Repurchased 0.9 million shares for $0.38 billion in Q2 2026.
- Forecasts 2026 worldwide da Vinci procedure growth of 13.5% to 15.5%.
- Ended Q2 2026 with $8.63 billion in cash, cash equivalents, and investments.
Price Impact
More from ISRG
Intuitive Surgical Appoints Taylor Patton as New Chief Commercial Officer
Intuitive Promotes Taylor Patton to Chief Commercial & Marketing Officer
Intuitive Surgical Unveils da Vinci 5 Innovations; Extends Instrument Use